Radius Health Creative Limited
Unaudited Financial Statements
For the year ended 28 February 2025
Pages for Filing with Registrar
Company Registration No. 12888079 (England and Wales)
Radius Health Creative Limited
Contents
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 6
Radius Health Creative Limited
Balance Sheet
As at 28 February 2025
Page 1
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
8,363
6,217
Current assets
Debtors
4
236,304
303,699
Cash at bank and in hand
842,586
666,734
1,078,890
970,433
Creditors: amounts falling due within one year
5
(222,589)
(238,417)
Net current assets
856,301
732,016
Net assets
864,664
738,233
Capital and reserves
Called up share capital
6
2
2
Profit and loss reserves
864,662
738,231
Total equity
864,664
738,233

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 13 October 2025 and are signed on its behalf by:
C Valdez
Director
Company Registration No. 12888079
Radius Health Creative Limited
Statement of Changes in Equity
For the year ended 28 February 2025
Page 2
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 March 2023
2
359,606
359,608
Year ended 29 February 2024:
Profit and total comprehensive income for the year
-
433,625
433,625
Dividends
-
(55,000)
(55,000)
Balance at 29 February 2024
2
738,231
738,233
Year ended 28 February 2025:
Profit and total comprehensive income for the year
-
282,541
282,541
Dividends
-
(156,110)
(156,110)
Balance at 28 February 2025
2
864,662
864,664
Radius Health Creative Limited
Notes to the Financial Statements
For the year ended 28 February 2025
Page 3
1
Accounting policies
Company information

Radius Health Creative Limited is a private company limited by shares incorporated in England and Wales. The registered office is 6th Floor Charlotte Building, 17 Gresse Street, London, United Kingdom, W1T 1QL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recover ed.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
30% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Radius Health Creative Limited
Notes to the Financial Statements (Continued)
For the year ended 28 February 2025
1
Accounting policies
(Continued)
Page 4
1.5
Financial instruments

The Company only has basic financial instruments measured at amortised cost, with no financial instruments classified as other or basic instruments measured at fair value.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.8
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
3
Radius Health Creative Limited
Notes to the Financial Statements (Continued)
For the year ended 28 February 2025
Page 5
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 March 2024
14,309
Additions
6,730
Disposals
(720)
At 28 February 2025
20,319
Depreciation and impairment
At 1 March 2024
8,092
Depreciation charged in the year
4,584
Eliminated in respect of disposals
(720)
At 28 February 2025
11,956
Carrying amount
At 28 February 2025
8,363
At 29 February 2024
6,217
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
217,571
284,763
Other debtors
18,733
18,936
236,304
303,699
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
88,556
65,852
Corporation tax
94,009
145,310
Other taxation and social security
31,630
16,930
Other creditors
2,806
4,737
Accruals and deferred income
5,588
5,588
222,589
238,417
Radius Health Creative Limited
Notes to the Financial Statements (Continued)
For the year ended 28 February 2025
Page 6
6
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 0.01p each
2,222
2,222
2
2

7
Ultimate controlling party

The re is no ultimate controlling party.

2025-02-28 2024-03-01 false false false CCH Software CCH Accounts Production 2025.200 No description of principal activity C Valdez M Taylor L Sian 12888079 2024-03-01 2025-02-28 12888079 2025-02-28 12888079 2024-02-29 12888079 core:OtherPropertyPlantEquipment 2025-02-28 12888079 core:OtherPropertyPlantEquipment 2024-02-29 12888079 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 12888079 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 12888079 core:ShareCapital 2025-02-28 12888079 core:ShareCapital 2024-02-29 12888079 core:RetainedEarningsAccumulatedLosses 2025-02-28 12888079 core:RetainedEarningsAccumulatedLosses 2024-02-29 12888079 core:ShareCapital 2023-02-28 12888079 core:RetainedEarningsAccumulatedLosses 2023-02-28 12888079 core:ShareCapitalOrdinaryShareClass1 2025-02-28 12888079 core:ShareCapitalOrdinaryShareClass1 2024-02-29 12888079 bus:Director1 2024-03-01 2025-02-28 12888079 core:RetainedEarningsAccumulatedLosses 2023-03-01 2024-02-29 12888079 2023-03-01 2024-02-29 12888079 core:RetainedEarningsAccumulatedLosses 2024-03-01 2025-02-28 12888079 core:ComputerEquipment 2024-03-01 2025-02-28 12888079 core:OtherPropertyPlantEquipment 2024-02-29 12888079 core:OtherPropertyPlantEquipment 2024-03-01 2025-02-28 12888079 core:CurrentFinancialInstruments 2025-02-28 12888079 core:CurrentFinancialInstruments 2024-02-29 12888079 bus:OrdinaryShareClass1 2024-03-01 2025-02-28 12888079 bus:OrdinaryShareClass1 2025-02-28 12888079 bus:OrdinaryShareClass1 2024-02-29 12888079 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 12888079 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 12888079 bus:FRS102 2024-03-01 2025-02-28 12888079 bus:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 12888079 bus:Director2 2024-03-01 2025-02-28 12888079 bus:Director3 2024-03-01 2025-02-28 12888079 bus:FullAccounts 2024-03-01 2025-02-28 xbrli:pure xbrli:shares iso4217:GBP